Lucretia Long, Staci S Reynolds, Lisa S Lewis, Michelle A Webb, Crystal Epley, Sarita Maturu
{"title":"Evaluation of a Seizure Action Plan in an Adult Epilepsy Center.","authors":"Lucretia Long, Staci S Reynolds, Lisa S Lewis, Michelle A Webb, Crystal Epley, Sarita Maturu","doi":"10.1212/CPJ.0000000000200275","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Seizure action plans (SAPs) provide valuable information for patients to manage seizure emergencies, but are underutilized in adult epilepsy centers. The purpose of this project was to implement a structured SAP for adult patients with epilepsy.</p><p><strong>Methods: </strong>A pre/postimplementation design was used. Provider SAP utilization rates were analyzed over a 16-week period. A pre and postimplementation survey assessed participant perceived impact of the SAP on knowledge and comfort associated with managing seizure emergencies. Provider barriers and facilitators were also assessed.</p><p><strong>Results: </strong>Average provider SAP utilization rate was 51.45%. A total of 204 participants completed the surveys, which showed a significant increase in knowledge and comfort for all items, <i>p</i> < 0.001. At postsurvey analysis, 98% of participants felt that all patients with epilepsy should have a SAP regardless of seizure burden.</p><p><strong>Discussion: </strong>Implementing a structured SAP increased provider utilization and patient and care partner knowledge and comfort of managing seizure emergencies.</p>","PeriodicalId":19136,"journal":{"name":"Neurology. Clinical practice","volume":null,"pages":null},"PeriodicalIF":2.3000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10997209/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurology. Clinical practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1212/CPJ.0000000000200275","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/4/4 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Seizure action plans (SAPs) provide valuable information for patients to manage seizure emergencies, but are underutilized in adult epilepsy centers. The purpose of this project was to implement a structured SAP for adult patients with epilepsy.
Methods: A pre/postimplementation design was used. Provider SAP utilization rates were analyzed over a 16-week period. A pre and postimplementation survey assessed participant perceived impact of the SAP on knowledge and comfort associated with managing seizure emergencies. Provider barriers and facilitators were also assessed.
Results: Average provider SAP utilization rate was 51.45%. A total of 204 participants completed the surveys, which showed a significant increase in knowledge and comfort for all items, p < 0.001. At postsurvey analysis, 98% of participants felt that all patients with epilepsy should have a SAP regardless of seizure burden.
Discussion: Implementing a structured SAP increased provider utilization and patient and care partner knowledge and comfort of managing seizure emergencies.
背景:癫痫发作行动计划(SAP癫痫发作行动计划(SAP)为患者处理癫痫发作紧急情况提供了宝贵的信息,但在成人癫痫中心却未得到充分利用。本项目旨在为成年癫痫患者实施结构化的癫痫发作行动计划:方法:采用实施前/后设计。对医疗机构在 16 周内的 SAP 使用率进行了分析。通过实施前和实施后调查,评估了参与者对 SAP 对癫痫发作紧急情况处理相关知识和舒适度的影响。此外,还对医疗机构的障碍和促进因素进行了评估:医疗机构 SAP 的平均使用率为 51.45%。共有 204 名参与者完成了调查,结果显示所有项目的知识和舒适度都有显著提高,P < 0.001。在调查后的分析中,98% 的参与者认为,无论癫痫发作负担如何,所有癫痫患者都应进行 SAP:讨论:实施结构化 SAP 提高了医疗服务提供者的利用率以及患者和护理伙伴对处理癫痫发作紧急情况的了解和舒适度。
期刊介绍:
Neurology® Genetics is an online open access journal publishing peer-reviewed reports in the field of neurogenetics. The journal publishes original articles in all areas of neurogenetics including rare and common genetic variations, genotype-phenotype correlations, outlier phenotypes as a result of mutations in known disease genes, and genetic variations with a putative link to diseases. Articles include studies reporting on genetic disease risk, pharmacogenomics, and results of gene-based clinical trials (viral, ASO, etc.). Genetically engineered model systems are not a primary focus of Neurology® Genetics, but studies using model systems for treatment trials, including well-powered studies reporting negative results, are welcome.